- Recent Funding
- Investors
- Enterprise Singapore
Enterprise Singapore portfolio
Enterprise Singapore has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Dayta AI's $1.8M Seed round in March 2022, alongside ROBO Global, EC Healthcare, Grosvenor Group and 4 others. That company is in Sales and marketing.
What Enterprise Singapore invests in
- Sales and marketing · 1 · 100%
- Health and bio · 1 · 100%
- Data and analytics · 1 · 100%
How Enterprise Singapore invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Seed | 1 100% | $1.8M |
Enterprise Singapore portfolio companies
| Company | Round with Enterprise Singapore | Total raised | Latest raise |
|---|---|---|---|
Sales and marketing |
Seed · $1.8M | $1.8M | Aug 20, 2026 Series B+ |
Most frequent co-investors
RROBO Global1 shared round · last Mar 22, 2022
- EEC Healthcare1 shared round · last Mar 22, 2022
GGrosvenor Group1 shared round · last Mar 22, 2022
IICCP Venture Partners1 shared round · last Mar 22, 2022
XXcel Next Ventures1 shared round · last Mar 22, 2022
- AAbacus Tech1 shared round · last Mar 22, 2022
SSBI Ven Capital1 shared round · last Mar 22, 2022
Similar investors
CCove Hill Partners1 company
SSomersault Ventures2 companies · 1 deal in 12 mo
SSequoia Capital Global Equities4 companies
AAraya Ventures5 companies · 4 deals in 12 moCCervin Ventures5 companies · 3 deals in 12 mo
FFifth Down Capital6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Sales and marketing).
How this is counted
Share is of the 1 round on Recent Funding that name Enterprise Singapore. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Enterprise Singapore, which is a subset of its real portfolio. API: /api/v1/investors/enterprise-singapore (get a free API key). More: the most active VC firms and new venture capital funds.